HI
Holobiome, Inc.
SEC filingBiotechnology · Boston, MA
Amount raised$10Msold at filing
Total offering$10M
Investors in the raise5count reported to the SEC
FiledJul 22, 2026first sale Dec 24, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Iain ChessellDirector
Philip StrandwitzExecutive Officer, Director
Michael LaFleurExecutive Officer
Joan LaRovereDirector
Executive officers, directors and promoters as listed on the Form D.